
ZymoChem
United States · Biotech & life sciences · Series A

Legit.Health
Spain · HealthTech · Seed
Compatibility /100
53/100
High potentialWhy talk
- Complementary sectors: Biotech & life sciences × HealthTech — room for a joint offer or co-selling.
- ZymoChem is one step ahead of Legit.Health (Seed): ZymoChem can share its playbook.
- Legit.Health likely needs funding for the next round — ZymoChem can offer investor introductions (inferred from public profile).
Score anatomy
Each segment is what one dimension adds, out of 100.
Score by goal
Dimension by dimension
Needs ↔ offers
6.5 / 10 pts
Value flows both ways.
- Legit.Health likely needs funding for the next round — ZymoChem can offer investor introductions (inferred from public profile).
- ZymoChem likely needs first paying customers — Legit.Health (Spain, Seed, $5.7M raised, strong traction) can offer access to its customer base (inferred from public profile).
Market bridge
2.5 / 10 pts
Distant markets.
- Legit.Health is based in Spain (Europe): a landing pad on another continent, both ways.
Customer potential
4.3 / 5 pts
Strong customer or channel potential.
- Legit.Health has strong traction in a related sector (HealthTech): CE-marked medical device (ISO 13485), with partners listed such as NHS, SERMAS, SESPA, Sanitas, Adeslas, Novartis and Almirall — a proven go-to-market and customer relationships ZymoChem can learn from or tap.
Sector synergy
25.0 / 50 pts
Complementary sectors.
- Complementary sectors: Biotech & life sciences × HealthTech — room for a joint offer or co-selling.
Stage complementarity
15.0 / 25 pts
Useful peer or mentor link.
- ZymoChem is one step ahead of Legit.Health (Seed): ZymoChem can share its playbook.
How the score works
Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “Peers”: Needs ↔ offers 10, Market bridge 10, Customer potential 5, Sector synergy 50, Stage complementarity 25. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.
Potential blends compatibility (65%) with the mean global score of both startups (35%): 56/100 — high from 50, medium from 36.